advertising_left.gif     advertising_right.gif
logo_sub_sheet.gif
 
   
HomeSubscribeAdvertisingPast 3 IssuesStaff My AccountHelpContact



June 23, 2008 Issue Volume 70, Number 25
Lead Stories for this Issue
  • Medical Schools Take Stand Against Industry Gifts While AMA Sits Out Debate
  • Pediatric Psoriasis Patients’ Access To Enbrel Is Factor In Committee Nod
  • With A Novel Pipeline, Pfizer Tries A New Oncology Business Unit Too
    Go to this Issue >>

  • June 16, 2008 Issue Volume 70, Number 24
    Lead Stories for this Issue
  • From Playing It Safe To All-In: Genentech Takes Risks With Oncology Pipeline
  • Novartis’ Analytic Capabilities A Key Part Of WellPoint Health IT Pilot
  • Hypertensives May Get Class Outcome Labels; Industry Wary Of Broad Efficacy
    Go to this Issue >>

  • June 9, 2008 Issue Volume 70, Number 23
    Lead Stories for this Issue
  • AVADO Presented At ASCO; But After The Fanfare, What Does It Signify?
  • FDA Chief Scientist Torti’s Plan For First 100 Days Centers On Excellence
  • Off-Label Dissemination Keeps FDA Stuck Between Prosecutors And Firms
    Go to this Issue >>

  • search within:
     


    HomeSubscribeAdvertisingPast 3 IssuesStaff My AccountHelpContact

      FDC Reports is the publisher of "The Pink Sheet"; "The Pink Sheet" DAILY; "The Gray Sheet"; FDAAdvisoryCommittee.com; "The Tan Sheet"; "The Rose Sheet"; Pharmaceutical Approvals Monthly; "The Gold Sheet"; "The Silver Sheet"; Health News Daily; PharmAsia News, an Elsevier company.